Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation
Friday, July 28, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

READ MORE >
GE Healthcare recall TruSignal SpO2 sensors
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

Share on Twitter Share on Facebook Share on Linkedin
GE Healthcare recall TruSignal SpO2 sensors
There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Abiomed's new FDA approval | Cardiovascular groups denounce racism, violence | NOACs outperform warfarin
Practice Management | June 2020
FDA recalls extended-release metformin | 4 cardiac arrhythmias associated with COVID-19 | When volumes should normalize
Week in Review: TCT 2020 & COVID-19 | TAVR for patients with bicuspid valves | DAEDALUS study results | Selatogrel
Month in Review: 10 Trending Stories from May
TAVR viable for patients with bicuspid valves | A historic map of the heart | Celebrated cardiologist dies from COVID-19
TCT 2020 goes virtual | An update on the AHA's COVID-19 patient data registry | DAEDALUS study results

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …341
    • Page 342
    • Page 343
    • Page 344
    • Current page 345
    • Page 346
    • Page 347
    • Page 348
    • Page 349 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup